Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Latest filing published 27 Apr 2026 for Amicus Therapeutics, INC., €12.5M. Read the official filing
Filing timeline
BuySaleBradley L. Campbell
Insider track record
Disclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Bradley L. Campbell: trading record in brief
Bradley L. Campbell (senior executive) discloses dealings in Amicus Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 4 January 2016 to 27 April 2026, the count stands at 76 filings.
Sales make up the whole of the open-market record (9 sales, €944k). Outside the open market, there are 18 share grants and 48 option exercises. Since January 2026: no purchases and 1 sale on the market.
The newest entry dates from 27 April 2026: a transaction of €12.5M, in Amicus Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Bradley L. Campbell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations76 total
1,008,680 shares@ US$14.500.31% mcap68.5% of flowCommon StockSEC:0001193125-26-182241:0
22,500 shares@ US$14.34841.4% of flowCommon StockSEC:0001193125-26-092114:0
75,000 shares@ US$6.102.0% of flowCommon StockSEC:0001193125-26-019838:0
108,602 shares@ US$14.2522.9% of flowCommon StockSEC:0001193125-25-337338:0
70,426 shares@ US$9.032.9% of flowCommon StockSEC:0001193125-25-323151:0
14,587 shares@ US$9.030.6% of flowCommon StockSEC:0001193125-25-307200:0
14,587 shares@ US$9.030.6% of flowCommon StockSEC:0001193125-25-301018:0
13,375 shares@ US$8.901.9% of flowCommon StockSEC:0000950170-25-041503:0
400 shares@ US$9.030.1% of flowCommon StockSEC:0000950170-25-025118:0
137,075 shares0Common StockSEC:0000950170-25-020034:0
20,647 shares@ US$9.313.2% of flowCommon StockSEC:0000950170-25-002425:0
7,500 shares@ US$8.611.1% of flowCommon StockSEC:0000950170-24-132964:0
7,500 shares@ US$10.01661.2% of flowCommon StockSEC:0000950170-24-132964:1
7,901 shares@ US$12.281.5% of flowCommon StockSEC:0000950170-24-123557:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-120981:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-112905:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-104073:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-091099:0
6,100 shares@ US$10.00481.0% of flowCommon StockSEC:0000950170-24-082476:1
6,100 shares@ US$8.610.8% of flowCommon StockSEC:0000950170-24-082476:0
1,400 shares@ US$8.610.2% of flowCommon StockSEC:0000950170-24-081542:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-069357:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-053058:0
7,500 shares@ US$8.611.0% of flowCommon StockSEC:0000950170-24-041367:0
13,375 shares@ US$11.482.5% of flowCommon StockSEC:0000950170-24-033713:0
25 of 76 declarations
